Short-and Long-Term Clinical Outcomes of Infliximab in Fulminant Ulcerative Colitis

Table 2

Late colectomy in patients with fulminant colitis.

	Late colectomy	Time to late; colectomy	No. without; colectomy	Total observation; time without colectomy
Active; Control	6/13	17 (7–37)	7	60 (26–91)
IFX	0/7		7	40 (20–58)
All IFX	6/20	17 (7–37)	14	52 (20–91)
Control
No IFX	1/3	12	2	19 (2–36)

Continuous variables are median (min-max). Time: in months. IFX: infliximab.